Ideaya Biosciences Inc (NASDAQ: IDYA) is -24.70% lower on its value in year-to-date trading and has touched a low of $25.20 and a high of $47.74 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IDYA stock was last observed hovering at around $26.60 in the last trading session, with the day’s gains setting it 0.19%.
Currently trading at $26.79, the stock is -7.28% and -11.83% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.4 million and changing 0.71% at the moment leaves the stock -29.53% off its SMA200. IDYA registered -15.22% loss for a year compared to 6-month loss of -28.96%. The firm has a 50-day simple moving average (SMA 50) of $30.3858 and a 200-day simple moving average (SMA200) of $38.016674.
The stock witnessed a -8.25% gain in the last 1 month and extending the period to 3 months gives it a -32.69%, and is 0.56% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.57% over the week and 5.08% over the month.
Ideaya Biosciences Inc (IDYA) has around 124 employees, a market worth around $2.33B and $3.92M in sales. Profit margin for the company is -4540.40%. Distance from 52-week low is 6.31% and -43.88% from its 52-week high. The company has generated returns on investments over the last 12 months (-14.85%).
with sales reaching $4.71M over the same period.The EPS is expected to shrink by -26.65% this year, but quarterly earnings will post -79.84% year-over-year. Quarterly sales are estimated to grow 20.17% in year-over-year returns.
Ideaya Biosciences Inc (IDYA) Top Institutional Holders
305.0 institutions hold shares in Ideaya Biosciences Inc (IDYA), with institutional investors hold 112.07% of the company’s shares. The shares outstanding are 86.43M, and float is at 77.21M with Short Float at 12.05%. Institutions hold 110.91% of the Float.
The top institutional shareholder in the company is FMR LLC with over 11.27 million shares valued at $395.69 million. The investor’s holdings represent 14.4557% of the IDYA Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 6.81 million shares valued at $239.02 million to account for 8.7321 of the shares outstanding. The other top investors are FEDERATED HERMES, INC. which holds 4.86 million shares representing 6.2283% and valued at over $170.49 million, while VANGUARD GROUP INC holds 5.4728 of the shares totaling 4.27 million with a market value of $149.81 million.
Ideaya Biosciences Inc (IDYA) Insider Activity
#####
Ideaya Biosciences Inc disclosed in a document filed with the SEC on May 29 ’24 that WHITE MICHAEL ANTHONY (Chief Scientific Officer) sold a total of 28,500 shares of the company’s common stock. The trade occurred on May 29 ’24 and was made at $36.24 per share for $1.03 million. Following the transaction, the insider now directly holds 0.0 shares of the IDYA stock.
Still, SEC filings show that on May 15 ’24, Hata Yujiro S (President and CEO) disposed off 83,856 shares at an average price of $42.90 for $3.6 million. The insider now directly holds 677,887 shares of Ideaya Biosciences Inc (IDYA).
